Related Experiment Video
Updated: Jul 18, 2026

Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
Evidence for conformational changes of poliovirus precursor particles during virus morphogenesis
Abstract:
Antisera raised against isolated structural polypeptides VP1, VP2 and VP3 of poliovirus type 1, strain Mahoney, reveal a differential reaction against mature virus and its precursor particles. During virus morphogenesis antigenic sites recognized by VP1 and VP2 antisera are lost stepwise from the surface of precursor particles. These sites are cross-reacting between serotypes and are also lost from precursor particles of type 2 (MEF-1) and type 3 (Saukett). They are absent on the surface of mature virus of all three serotypes. In contrast, the VP3 antiserum recognizes sites expressed maximally on the surface of infectious virus of type 1 (Mahoney). This antiserum did not show significant intertypic cross-reactions with virus particles, empty capsids or 14S particles of poliovirus types 2 and 3. However, it does recognize intertypic cross-reacting sites, like the VP1 and VP2 antisera, on denatured polypeptides and 5S particles of each serotype.
Insights
Antigenic sites on poliovirus precursor particles, recognized by VP1 and VP2 antibodies, are lost during maturation and are absent in mature virus. VP3 antibodies identify sites on mature type 1 poliovirus, with limited cross-reactivity between serotypes.
Area of Science:
- Virology
- Structural Biology
- Immunology
Background:
- Poliovirus structure and assembly are complex processes involving multiple polypeptide components.
- Understanding the antigenic properties of poliovirus at different stages of its life cycle is crucial for vaccine development and antiviral strategies.
Purpose of the Study:
- To investigate the differential antigenic reactivity of poliovirus structural polypeptides (VP1, VP2, VP3) during virus morphogenesis.
- To characterize the serotype-specific and cross-reacting antigenic sites on mature poliovirus and its precursor particles.
Main Methods:
- Production of antisera against isolated poliovirus type 1 structural polypeptides (VP1, VP2, VP3).
- Testing the reactivity of these antisera against mature poliovirus and precursor particles of different serotypes (type 1, 2, and 3).
- Analysis of antigenic site expression on denatured polypeptides and various particle intermediates (5S, 14S).
Main Results:
- VP1 and VP2 antisera recognized antigenic sites on precursor particles that were progressively lost during morphogenesis.
- These VP1/VP2-recognized sites showed intertypic cross-reactivity and were absent on mature virus of all three serotypes.
- VP3 antiserum identified sites maximally expressed on mature type 1 poliovirus, with minimal cross-reactivity on intact particles of other serotypes.
- VP3 antiserum recognized intertypic cross-reacting sites on denatured polypeptides and 5S particles.
Conclusions:
- Antigenic sites on poliovirus precursor particles, recognized by VP1 and VP2, are transient and serotype-cross-reactive.
- The VP3 antigenic site is primarily associated with mature, infectious type 1 poliovirus and shows limited intertypic cross-reactivity on intact particles.
- These findings highlight distinct antigenic profiles during poliovirus assembly and maturation, with implications for serological assays and vaccine design.
Related Concept Videos
Viral Structure
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Leaky Scanning
Pinching-off of Coated Vesicles
Poliomyelitis
Inhibitors of Virion Maturation and Assembly

